Protective effect of different flavonoids against endothelial senescence via NLRP3 inflammasome

被引:12
作者
Sun, Chunhui [1 ]
Wang, Xin [1 ]
Zheng, Guihong [1 ]
Fan, Shaohua [1 ]
Lu, Jun [1 ]
Zhang, Zifeng [1 ]
Wu, Dongmei [1 ]
Shan, Qun [1 ]
Hu, Bin [1 ]
Zheng, Yuanlin [1 ]
机构
[1] Jiangsu Normal Univ, Sch Life Sci, Key Lab Biotechnol Med Plants Jiangsu Prov, Xuzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Endothelial senescence; Flavonoids; High glucose; NLRP3; inflammasome; Reactive oxygen species; CELLULAR SENESCENCE; TROXERUTIN PROTECTS; OXIDATIVE STRESS; NITRIC-OXIDE; D-GALACTOSE; REPLICATIVE SENESCENCE; MARKER PROTEIN-30; IMMUNE-RESPONSES; GENE-EXPRESSION; CELLS;
D O I
10.1016/j.jff.2016.08.031
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Senescence of vascular endothelial cells promotes endothelial dysfunction and contributes to the progression of cardiovascular diseases. It is imperative to explore effective methods to suppress endothelial senescence. Herein, we found flavonoids including quercetin, puerarin and troxerutin, which exist in normal diet and extracted from traditional herbs, delayed D-glucose-induced endothelial senescence and restored endothelial functions. In the process, D-glucose amplified endogenous reactive oxygen species (ROS) level and subsequently promoted NLRP3 inflammasome activation. However, these alterations were reversed by flavonoids. Meanwhile, clearance of ROS or interference of NLRP3 function by specific siRNA attenuated high glucose-induced senescence but advanced the anti-senescent impact of flavonoids. On the contrary, the preventive effect of flavonoids on senescence was disturbed once NLRP3 inflammasome was overactivated. Our studies suggest that flavonoids can inhibit high glucose-induced endothelial premature senescence by suppressing NLRP3 inflammasome activity, which may be a useful therapeutic strategy to alleviate endothelial senescence related vascular diseases. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:598 / 609
页数:12
相关论文
共 50 条
  • [41] Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome
    Zhao, Jijun
    Wang, Jihui
    Zhou, Mianjing
    Li, Mengyuan
    Li, Meirong
    Tan, Hechang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 69 : 213 - 216
  • [42] Nanoparticle fullerol alleviates radiculopathy via NLRP3 inflammasome and neuropeptides
    Jin, Li
    Ding, Mengmeng
    Oklopcic, Azra
    Aghdasi, Bayan
    Xiao, Li
    Li, Ziyi
    Jevtovic-Todorovic, Vesna
    Li, Xudong
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (06) : 2049 - 2059
  • [43] Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosis
    Shen, Zherui
    Huang, Demei
    Jia, Nan
    Zhao, Sijing
    Pei, Caixia
    Wang, Yilan
    Wu, Yongcan
    Wang, Xiaomin
    Shi, Shihua
    Wang, Fei
    He, Yacong
    Wang, Zhenxing
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [44] NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
    Wan, Zhaofei
    Fan, Yan
    Liu, Xiaojun
    Xue, Jiahong
    Han, Zhenhua
    Zhu, Canzhan
    Wang, Xinhong
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 1931 - 1942
  • [45] NLRP3 in protective immunity and vaccination against respiratory infection
    Lavelle, Ed C.
    McNaughton, Anne
    McNeela, Edel
    EXPERT REVIEW OF VACCINES, 2011, 10 (03) : 255 - 257
  • [46] NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
    Gora, Ilona M.
    Ciechanowska, Anna
    Ladyzynski, Piotr
    CELLS, 2021, 10 (02) : 1 - 29
  • [47] Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke
    Du, Xiaoxue
    Amin, Nashwa
    Xu, Linhao
    Botchway, Benson O. A.
    Zhang, Bo
    Fang, Marong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [48] PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway
    Deng, Yaping
    Han, Xue
    Yao, Zheng
    Sun, Yuannan
    Yu, Jiawen
    Cai, Jian
    Ren, Guofei
    Jiang, Guojun
    Han, Feng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (06) : 2255 - 2266
  • [49] Improvement Effect of Soyeom Pharmacopuncture on Gout via NLRP3 Inflammasome Regulation
    Kim, Sung Wook
    Lee, Jun Ho
    Kim, Hyeonjin
    Lee, Seong Hoon
    Jeong, Dajeong
    Kim, Hyuk Soon
    Lee, Cheol-Jung
    Kim, Dae Yong
    Yook, Tae Han
    Yang, Gabsik
    JOURNAL OF PHARMACOPUNCTURE, 2022, 25 (04) : 396 - 403
  • [50] Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
    Wang, Hao-yu
    Lin, Xi
    Huang, Guan-gen
    Zhou, Rong
    Lei, Shu-yue
    Ren, Jing
    Zhang, Kai-rong
    Feng, Chun-lan
    Wu, Yan-wei
    Tang, Wei
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (08) : 1687 - 1700